Bookmark
Forward
Vascular effects of RWJ-676070, a selective combined V1a/V2 vasopressin receptor antagonist.
L Coltamai, M Bucher, M P Maillard, U Shukla, N Bohidar, L Haskell, K Bertelsen, M Fedgchin, B Vogt, M Burnier
Department of Medicine, Division of Nephrology and Hypertension, Central University Hospital of Vaud, Lausanne, Switzerland.
Clinical pharmacology and therapeutics 2009 FebSizes of these terms reflect their relevance to your search.
No abstract available.
Citation
L Coltamai, M Bucher, M P Maillard, U Shukla, N Bohidar, L Haskell, K Bertelsen, M Fedgchin, B Vogt, M Burnier. Vascular effects of RWJ-676070, a selective combined V1a/V2 vasopressin receptor antagonist. Clinical pharmacology and therapeutics. 2009 Feb;85(2):145-8
Mesh Tags
Substances
PMID: 18987622
View Full Text
